Evaluation of the genotype mtbdr assay for rapid detection of rifampin and isoniazid resistance in clinical mycobacterium tuberculosis complex clinical isolates;Mycobacterium tuberculosis kompleksi̇ kli̇ni̇k i̇zolatlarinda ri̇fampi̇si̇n ve i̇zoni̇azi̇d di̇renci̇ni̇n hizli tespi̇ti̇nde "genotype mtbdr" testi̇ni̇n deǧerlendi̇ri̇lmesi̇

Mikrobiyoloji Bulteni

Volumn 43, Issue 2, 2009, Pages 217-226

  Aslan, Gönül ^a   Tezcan, Seda ^a   Emekdaş, Gürol ^a  

^a MERSIN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Genotype MTBDR assay; Isoniazid; Mycobacterium tuberculosis; Resistance; Rifampin

Indexed keywords

BACTERIAL DNA; BACTERIAL PROTEIN; CATALASE; ISONIAZID; KATG PROTEIN, MYCOBACTERIUM TUBERCULOSIS; RIFAMPICIN; RPOB PROTEIN, MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSTATIC AGENT;

ARTICLE; CHEMISTRY; CLASSIFICATION; DRUG EFFECT; GENETICS; GENOTYPE; HUMAN; MICROBIOLOGY; MULTIDRUG RESISTANCE; MUTATION; MYCOBACTERIUM TUBERCULOSIS; TIME; TUBERCULOSIS;

ANTIBIOTICS, ANTITUBERCULAR; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CATALASE; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENOTYPE; HUMANS; ISONIAZID; MUTATION; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; TIME FACTORS; TUBERCULOSIS;

EID: 67649554029     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Brossier F, Veziris N, Truffot-Pernot C, Jarlier V, Sougakoff W. Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance. J Clin Microbiol 2006; 44: 3659-64.
2. Hillemann D, Weizenegger M, Kubica T, Richter E, Niemann S. Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2005; 43: 3699-703.
3. Parsons LM, Salfinger M, Clobridge A, et al. Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol. Antimicrob Agents Chemother 2005; 49: 2218-25.
4. Kiepiela P, Bishop KS, Smith AN, Roux L, York DF. Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. Tuber Lung Dis 2000; 80: 47-56.
5. Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 1998; 79: 3-29.
6. Somoskovi A, Parsons LM, Salfinger M. The molecular basis of resistance to isoniazid, rifampin, and pyrazi-namide in Mycobacterium tuberculosis. Respir Res 2001; 2: 164-8.
7. Ahmad S, Mustafa AS. Molecular diagnosis of drug-resistant tuberculosis. Kuwait Med J 2001; 33:120-126.
8. Ahmad S, Mokaddas E. The occurrence of rare rpoB mutations in rifampicin-resistant clinical Mycobacterium tuberculosis isolates from Kuwait. Int J Antimicrob Agents 2005; 26: 205-12.
9. Simon S, Listiawan I. Drug resistance in Mycobacterium tuberculosis: A molecular perspective. Madjalah Ke-dokt Indones 2003; 4: 26-35.
10. Ozturk CE, Sanic A, Kaya D, Ceyhan I. Molecular analysis of isoniazid, rifampin and streptomycin resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Duzce, Turkey. Jpn J Infect Dis 2005; 58: 309-12.
11. Bang D, Andersen ÅB, Thomsen VØ. Rapid genotypic detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens. J Clin Microbiol 2006; 44: 2605-08.
12. Sajduda A, Brzostek A, Poplawska M, et al. Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland. J Clin Microbiol 2004; 42: 2425-31.
13. Miotto P, Piana F, Penati V, Canducci F, Migliori GB, Cirillo DM. Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy. J Clin Microbiol 2006; 44: 2485-91.
14. Rossau R, Traore H, De Beenhouwer H, et al. Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob Agents Chemother 1997; 41: 2093-8.
15. Cavusoglu C, Hilmioglu S, Guneri S, Bilgic A. Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. J Clin Microbiol 2002; 40: 4435-8.
16. Makinen J, Marttila HJ, Marjamaki M, Viljanen MK, Soini H. Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2006; 44: 350-2.
17. Sachan AS, Gupta RK, Katoch VM, Mishra K, Jakhmola P. Detection of rifampicin resistant mutant gene in Mycobacterium tuberculosis by line probe assay. Ind J Tub 2001; 49: 209-11.
18. Lemus D, Martin A, Montoro E, Portaels F, Palomino JC. Rapid alternative methods for detection of rifampicin resistance in Mycobacterium tuberculosis. J Antimicrob Chemother 2004; 54: 130-3.
19. Cavusoglu C, Turhan A, Akinci P, Soyler I. Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis isolates. J Clin Microbiol 2006; 44: 2338-42.